NASDAQ:SLNO - Soleno Therapeutics News Headlines

Sign in or create an account to add this stock to your watchlist.
$2.40 +0.05 (+2.12 %)
(As of 03/22/2019 04:00 PM ET)
Previous Close$2.4050
Today's Range$2.16 - $2.62
52-Week Range$1.11 - $5.07
Volume812,396 shs
Average Volume4.59 million shs
Market Capitalization$51.54 million
P/E RatioN/A
Dividend YieldN/A
Beta3.29

Headlines

Soleno Therapeutics (NASDAQ SLNO) News Headlines

Source:
DateHeadline
Soleno Therapeutics Inc (SLNO) Expected to Announce Earnings of -$0.29 Per ShareSoleno Therapeutics Inc (SLNO) Expected to Announce Earnings of -$0.29 Per Share
www.americanbankingnews.com - March 22 at 6:16 PM
Larry N. Feinberg Acquires 130,363 Shares of Soleno Therapeutics Inc (SLNO) StockLarry N. Feinberg Acquires 130,363 Shares of Soleno Therapeutics Inc (SLNO) Stock
www.americanbankingnews.com - March 18 at 8:29 PM
Soleno Therapeutics down 3% on Q4 resultsSoleno Therapeutics down 3% on Q4 results
seekingalpha.com - March 18 at 7:23 PM
Soleno Therapeutics, Analyst Review and Pipeline ProgressSoleno Therapeutics, Analyst Review and Pipeline Progress
finance.yahoo.com - March 18 at 7:23 PM
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial ResultsSoleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2018 Financial Results
finance.yahoo.com - March 18 at 8:39 AM
51 Stocks Moving In Fridays Mid-Day Session - Benzinga51 Stocks Moving In Friday's Mid-Day Session - Benzinga
www.benzinga.com - March 16 at 9:03 AM
U.S. STOCKS ON THE MOVE-Tesla, Newell, Broadcom, Adobe, Amazon, Facebook - NasdaqU.S. STOCKS ON THE MOVE-Tesla, Newell, Broadcom, Adobe, Amazon, Facebook - Nasdaq
www.nasdaq.com - March 16 at 9:03 AM
U.S. STOCKS ON THE MOVE-Tesla, Adobe, Amazon, Schlumberger, Facebook - NasdaqU.S. STOCKS ON THE MOVE-Tesla, Adobe, Amazon, Schlumberger, Facebook - Nasdaq
www.nasdaq.com - March 16 at 9:03 AM
U.S. STOCKS ON THE MOVE-Boeing, Tesla, GE, Facebook, Amazon, Adobe - NasdaqU.S. STOCKS ON THE MOVE-Boeing, Tesla, GE, Facebook, Amazon, Adobe - Nasdaq
www.nasdaq.com - March 16 at 9:03 AM
Soleno Therapeutics News: Why SLNO Stock Is Skyrocketing Today - Investorplace.comSoleno Therapeutics News: Why SLNO Stock Is Skyrocketing Today - Investorplace.com
investorplace.com - March 16 at 9:03 AM
Soleno Therapeutics 200% Spike: What You Need To KnowSoleno Therapeutics' 200% Spike: What You Need To Know
www.msn.com - March 15 at 7:02 PM
Four Healthcare Stocks Picking Up Speed On FridayFour Healthcare Stocks Picking Up Speed On Friday
finance.yahoo.com - March 15 at 7:02 PM
Soleno up 44% premarket on continuation of DCCR studySoleno up 44% premarket on continuation of DCCR study
seekingalpha.com - March 15 at 9:02 AM
Soleno Therapeutics Announces Positive Outcome from Planned Data Safety Monitoring Board Review of Phase III DESTINY PWS Clinical Trial of DCCR in Prader-Willi SyndromeSoleno Therapeutics Announces Positive Outcome from Planned Data Safety Monitoring Board Review of Phase III DESTINY PWS Clinical Trial of DCCR in Prader-Willi Syndrome
finance.yahoo.com - March 14 at 6:56 PM
Soleno Therapeutics to Participate in Two Upcoming Investor ConferencesSoleno Therapeutics to Participate in Two Upcoming Investor Conferences
finance.yahoo.com - March 11 at 7:14 PM
 Brokerages Expect Soleno Therapeutics Inc (SLNO) to Announce -$0.28 EPS Brokerages Expect Soleno Therapeutics Inc (SLNO) to Announce -$0.28 EPS
www.americanbankingnews.com - February 28 at 1:26 AM
Head to Head Analysis: 21st North (ULGX) & Soleno Therapeutics (SLNO)Head to Head Analysis: 21st North (ULGX) & Soleno Therapeutics (SLNO)
www.americanbankingnews.com - February 27 at 1:21 AM
Global Prader-Willi Syndrome Market Insights, Epidemiology and Market Forecasts 2018-2028 - GlobeNewswireGlobal Prader-Willi Syndrome Market Insights, Epidemiology and Market Forecasts 2018-2028 - GlobeNewswire
globenewswire.com - February 14 at 6:02 PM
An In-Depth Look At Soleno TherapeuticsAn In-Depth Look At Soleno Therapeutics
seekingalpha.com - February 13 at 6:14 PM
Soleno Therapeutics secures $16.5M capital raiseSoleno Therapeutics secures $16.5M capital raise
seekingalpha.com - December 19 at 5:27 PM
Soleno Therapeutics Announces $16.5 Million Private PlacementSoleno Therapeutics Announces $16.5 Million Private Placement
finance.yahoo.com - December 19 at 5:27 PM
Is Soleno Therapeutics, Inc.’s (NASDAQ:SLNO) CEO Pay Justified?Is Soleno Therapeutics, Inc.’s (NASDAQ:SLNO) CEO Pay Justified?
finance.yahoo.com - December 12 at 8:48 AM
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial ResultsSoleno Therapeutics Provides Corporate Update and Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 15 at 8:42 AM
Soleno Therapeutics Presents Clinical Fat Loss Data on DCCR at the Obesity Society Meeting 2018Soleno Therapeutics Presents Clinical Fat Loss Data on DCCR at the Obesity Society Meeting 2018
finance.yahoo.com - November 15 at 8:42 AM
Soleno Therapeutics presents clinical data on DCCR at 2018 FPWRSoleno Therapeutics presents clinical data on DCCR at 2018 FPWR
seekingalpha.com - October 8 at 4:36 PM
Soleno Therapeutics Presents Clinical Data on DCCR at 2018 Foundation for Prader-Willi Research Annual ConferenceSoleno Therapeutics Presents Clinical Data on DCCR at 2018 Foundation for Prader-Willi Research Annual Conference
finance.yahoo.com - October 8 at 8:29 AM
Soleno Therapeutics (SLNO) Announces Clinical Pharmacokinetic & Glycemic Impact Data from Studies of DCCR for Treatment of Prader-Willi SyndromeSoleno Therapeutics (SLNO) Announces Clinical Pharmacokinetic & Glycemic Impact Data from Studies of DCCR for Treatment of Prader-Willi Syndrome
www.streetinsider.com - October 1 at 8:39 AM
Soleno Therapeutics Presents Clinical Data on DCCR at Late-Breaking Session of European Society for Paediatric EndocrinologySoleno Therapeutics Presents Clinical Data on DCCR at Late-Breaking Session of European Society for Paediatric Endocrinology
finance.yahoo.com - October 1 at 8:39 AM
Soleno Therapeutics to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare DiseaseSoleno Therapeutics to Participate in Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease
finance.yahoo.com - September 19 at 8:51 AM
Soleno Therapeutics (SLNO) to Present DCCR Clinical Data at Late Breaking Sessions of ESPESoleno Therapeutics (SLNO) to Present DCCR Clinical Data at Late Breaking Sessions of ESPE
www.streetinsider.com - September 17 at 5:00 PM
Soleno Therapeutics to Present DCCR Clinical Data at Late Breaking Sessions of the European Society for Paediatric EndocrinologySoleno Therapeutics to Present DCCR Clinical Data at Late Breaking Sessions of the European Society for Paediatric Endocrinology
finance.yahoo.com - September 17 at 8:31 AM
Soleno Therapeutics (SLNO) Reports Expansion of Ongoing Phase III Trial of DCCR in Prader-Willi Syndrome to Include Younger PatientsSoleno Therapeutics (SLNO) Reports Expansion of Ongoing Phase III Trial of DCCR in Prader-Willi Syndrome to Include Younger Patients
www.streetinsider.com - September 8 at 8:34 AM
Soleno Therapeutics Announces Expansion of Ongoing Phase III Trial of DCCR in Prader-Willi Syndrome to Include Younger PatientsSoleno Therapeutics Announces Expansion of Ongoing Phase III Trial of DCCR in Prader-Willi Syndrome to Include Younger Patients
finance.yahoo.com - September 6 at 9:00 AM
Soleno Therapeutics Announces Issuance of New U.S. Patent for DCCR Covering Treatment of Low Lean Body Mass in Prader-Willi SyndromeSoleno Therapeutics Announces Issuance of New U.S. Patent for DCCR Covering Treatment of Low Lean Body Mass in Prader-Willi Syndrome
finance.yahoo.com - September 4 at 8:55 AM
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial ResultsSoleno Therapeutics Provides Corporate Update and Reports Second Quarter 2018 Financial Results
globenewswire.com - August 14 at 5:02 PM
Soleno Therapeutics receives Fast Track designation for DCCR for treatment of PWSSoleno Therapeutics receives Fast Track designation for DCCR for treatment of PWS
seekingalpha.com - July 30 at 4:55 PM
Soleno Therapeutics (SLNO) Reports Fast Track Designation from FDA for DCCR for Treatment of PWSSoleno Therapeutics (SLNO) Reports Fast Track Designation from FDA for DCCR for Treatment of PWS
www.streetinsider.com - July 30 at 4:55 PM
Soleno Therapeutics Receives Fast Track Designation from FDA for DCCR for Treatment of Prader-Willi SyndromeSoleno Therapeutics Receives Fast Track Designation from FDA for DCCR for Treatment of Prader-Willi Syndrome
finance.yahoo.com - July 30 at 4:55 PM
Soleno Therapeutics: Rare Disease Pick With Significant Potential And Low ValuationSoleno Therapeutics: Rare Disease Pick With Significant Potential And Low Valuation
seekingalpha.com - July 30 at 8:58 AM
Soleno Therapeutics To Present Corporate Update at the BIO International ConventionSoleno Therapeutics To Present Corporate Update at the BIO International Convention
finance.yahoo.com - June 4 at 8:46 AM
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial ResultsSoleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 16 at 8:57 AM
ADMA Braces For Busy Year, AMPH Gets FDA Nod, CHRS Faces Litmus Test In Nov.ADMA Braces For Busy Year, AMPH Gets FDA Nod, CHRS Faces Litmus Test In Nov.
www.nasdaq.com - May 15 at 9:06 AM
Soleno Therapeutics (SLNO) Reports Initiation of Phase III Clinical Trial of DCCR in Prader-Willi SyndromeSoleno Therapeutics (SLNO) Reports Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome
www.streetinsider.com - May 14 at 5:01 PM
Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi SyndromeSoleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome
finance.yahoo.com - May 14 at 9:09 AM
What Should You Know About Soleno Therapeutics Inc’s (NASDAQ:SLNO) Future?What Should You Know About Soleno Therapeutics Inc’s (NASDAQ:SLNO) Future?
finance.yahoo.com - April 4 at 8:50 AM
Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial ResultsSoleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
globenewswire.com - April 2 at 9:12 AM
Does Soleno Therapeutics Inc’s (NASDAQ:SLNO) Past Performance Indicate A Weaker Future?Does Soleno Therapeutics Inc’s (NASDAQ:SLNO) Past Performance Indicate A Weaker Future?
finance.yahoo.com - March 27 at 9:05 AM
Soleno Therapeutics Inc (NASDAQ:SLNO): Is Breakeven Near?Soleno Therapeutics Inc (NASDAQ:SLNO): Is Breakeven Near?
finance.yahoo.com - March 17 at 8:58 AM
BRIEF-Soleno Therapeutics Files For Resale Of Up To 14.2 Mln SharesBRIEF-Soleno Therapeutics Files For Resale Of Up To 14.2 Mln Shares
www.reuters.com - January 30 at 4:03 PM
BRIEF-Jack W. Schuler Living Trust Reports 13.4 Pct Stake In Soleno Therapeutics As Of December 15BRIEF-Jack W. Schuler Living Trust Reports 13.4 Pct Stake In Soleno Therapeutics As Of December 15
www.reuters.com - January 12 at 9:10 AM
This page was last updated on 3/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel